129 related articles for article (PubMed ID: 8481508)
1. Myeloblastic leukemia cells conditionally blocked by myc-estrogen receptor chimeric transgenes for terminal differentiation coupled to growth arrest and apoptosis.
Selvakumaran M; Liebermann D; Hoffman-Liebermann B
Blood; 1993 May; 81(9):2257-62. PubMed ID: 8481508
[TBL] [Abstract][Full Text] [Related]
2. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
3. Progression of the myeloid differentiation program is dominant to transforming growth factor-beta 1-induced apoptosis in M1 myeloid leukemic cells.
Selvakumaran M; Reed JC; Liebermann D; Hoffman B
Blood; 1994 Aug; 84(4):1036-42. PubMed ID: 8049423
[TBL] [Abstract][Full Text] [Related]
4. Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells.
Hoffman-Liebermann B; Liebermann DA
Oncogene; 1991 Jun; 6(6):903-9. PubMed ID: 1906157
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6- and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc.
Hoffman-Liebermann B; Liebermann DA
Mol Cell Biol; 1991 May; 11(5):2375-81. PubMed ID: 1901940
[TBL] [Abstract][Full Text] [Related]
6. Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells.
Medh RD; Wang A; Zhou F; Thompson EB
Oncogene; 2001 Aug; 20(34):4629-39. PubMed ID: 11498786
[TBL] [Abstract][Full Text] [Related]
7. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.
Minami M; Inoue M; Wei S; Takeda K; Matsumoto M; Kishimoto T; Akira S
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3963-6. PubMed ID: 8632998
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis and differentiation of human embryonic stem cells induced by sustained activation of c-Myc.
Sumi T; Tsuneyoshi N; Nakatsuji N; Suemori H
Oncogene; 2007 Aug; 26(38):5564-76. PubMed ID: 17369859
[TBL] [Abstract][Full Text] [Related]
9. Fos modulates myeloid cell survival and differentiation and partially abrogates the c-Myc block in terminal myeloid differentiation.
Shafarenko M; Amanullah A; Gregory B; Liebermann DA; Hoffman B
Blood; 2004 Jun; 103(11):4259-67. PubMed ID: 14982872
[TBL] [Abstract][Full Text] [Related]
10. GATA-1 blocks IL-6-induced macrophage differentiation and apoptosis through the sustained expression of cyclin D1 and bcl-2 in a murine myeloid cell line M1.
Tanaka H; Matsumura I; Nakajima K; Daino H; Sonoyama J; Yoshida H; Oritani K; Machii T; Yamamoto M; Hirano T; Kanakura Y
Blood; 2000 Feb; 95(4):1264-73. PubMed ID: 10666199
[TBL] [Abstract][Full Text] [Related]
11. Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis.
Selvakumaran M; Liebermann DA; Hoffman-Liebermann B
Mol Cell Biol; 1992 Jun; 12(6):2493-500. PubMed ID: 1588953
[TBL] [Abstract][Full Text] [Related]
12. Effects of type-beta 1 transforming growth factor on the proliferation and differentiation of mouse myelomonocytic leukemia cells (M1).
Michishita M; Hirayoshi K; Tsuru A; Nakamura N; Yoshida Y; Okuma M; Nagata K
Exp Cell Res; 1991 Sep; 196(1):107-13. PubMed ID: 1879463
[TBL] [Abstract][Full Text] [Related]
13. Deregulated E2F-1 blocks terminal differentiation and loss of leukemogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15(INK4B) and p16(INK4A).
Amanullah A; Hoffman B; Liebermann DA
Blood; 2000 Jul; 96(2):475-82. PubMed ID: 10887108
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in fibroblasts by c-myc protein.
Evan GI; Wyllie AH; Gilbert CS; Littlewood TD; Land H; Brooks M; Waters CM; Penn LZ; Hancock DC
Cell; 1992 Apr; 69(1):119-28. PubMed ID: 1555236
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
[TBL] [Abstract][Full Text] [Related]
16. The c-myc apoptotic response is not intrinsic to blocking terminal myeloid differentiation.
D'Angelo S; Liebermann D; Hoffman B
J Cell Physiol; 2008 Jul; 216(1):120-7. PubMed ID: 18247372
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
[TBL] [Abstract][Full Text] [Related]
18. Egr-1 abrogates the block imparted by c-Myc on terminal M1 myeloid differentiation.
Shafarenko M; Liebermann DA; Hoffman B
Blood; 2005 Aug; 106(3):871-8. PubMed ID: 15840692
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity to myc-induced apoptosis is retained in spontaneous and transplanted lymphomas of CD2-mycER mice.
Blyth K; Stewart M; Bell M; James C; Evan G; Neil JC; Cameron ER
Oncogene; 2000 Feb; 19(6):773-82. PubMed ID: 10698495
[TBL] [Abstract][Full Text] [Related]
20. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
Hoffman B; Amanullah A; Shafarenko M; Liebermann DA
Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
